Recently, Guangzhou YuanDong Biotechnology Co., Ltd. (hereinafter referred to as "YuanDong Bio") successfully completed a new round of financing. This round was led by DALTON Capital, with participation from Winzac Capital.
YuanDong Bio focuses on the integration of synthetic biology and artificial intelligence. The company has successfully constructed a world-leading production system for bacterial nanocellulose. By utilizing engineering strains "trained" by AI in coordination with advanced fermentation processes, the company has significantly shortened the production cycle. YuanDong Bio uses agricultural waste as raw material to efficiently produce high-value-added nanocellulose. This method is not only more environmentally friendly than traditional extraction from wood but also significantly reduces costs.
Furthermore, in addition to serving high-end industries, YuanDong Bio has addressed the long-standing pain point of chemical additive dependency in the cosmetics industry by launching a revolutionary "Bio-Nanocrystalline Cellulose" (BNC). This product serves as an alternative to traditional chemical emulsifiers commonly found in skincare products. Currently, this raw material has entered the supply chains of several well-known cosmetic companies for trials and product development. As production capacity expands, these bio-based products—which are both safe and enhance the skincare experience—will become available to the public at more affordable prices, making "tech-driven skincare" accessible to everyone.
Llinks acting as legal counsel to DALTON Capital, provided professional legal services for its participation in this new investment round for YuanDong Bio, leveraging its extensive experience in the investment and financing sector. The scope of service included conducting legal due diligence, designing the transaction structure, and drafting, revising, and coordinating transaction documents with the company. Based on its deep expertise in financing projects and high-quality legal services, the Llinks team facilitated the successful signing and closing of this investment between DALTON Capital and YuanDong Bio.
Llinks Engagement Team
Teddy Li, Partner
Alex Zhang, Contractual Partner
Alice Wang, Partner